Virology
TWiV 951: Clinical update with Dr. Daniel Griffin
By Vincent Racaniello | | This Week in Virology
In his weekly clinical update Dr. Griffin discusses Influenza incidence and vaccine effectiveness during the southern hemisphere influenza season in Chile, Nirsevimab for prevention of RSV infection in healthy late-preterm and term infants, severe Monkeypox in hospitalized patients, reinfections with different SARS-CoV-2 Omicron subvariants, impact of community masking on COVID-19 in Bangladesh, unadjuvanted intranasal spike vaccine elicits protective …
TWiV 951: Clinical update with Dr. Daniel Griffin Read More »
Antibodies Against SARS-CoV-2 Nucleocapsid Protein May Not Be Reliable Markers for Infection in Vaccinated People
By Gertrud U. Rey | | Basic virology, Gertrud Rey
by Gertrud U. Rey You are fully vaccinated against SARS-CoV-2 and have presumably never been infected with the virus. But how can you know for sure? One way to find out is by testing your blood for the presence of antibodies against the viral nucleocapsid protein, which can only be encountered during natural infection. This …
TWiV 950: Prion diseases with Richard Knight
By Vincent Racaniello | | This Week in Virology
From the European Society for Clinical Virology 2022 Conference in Manchester UK, Vincent speaks with Richard Knight about prion diseases and the outbreak of bovine spongiform encephalitis that led to cases of variant Creutzfeldt-Jakob disease in humans. Host: Vincent Racaniello Guest: Richard Knight Click arrow to playDownload TWiV 950 (68 MB .mp3, 114 min)Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become …
TWiV 949: Clinical update with Dr. Daniel Griffin
By Vincent Racaniello | | This Week in Virology
In his weekly clinical update Dr. Griffin discusses progress toward poliomyelitis eradication in Pakistan, polio by the numbers , influenza and COVID-19 vaccination coverage among health care personnel, phase 1/2a safety and immunogenicity of an adenovirus 26 vector RSV vaccine encoding prefusion F in adults 18–50 years and RSV seropositive children 12–24 months, receipt of first and second doses of JYNNEOS vaccine for prevention of Monkeypox, distinguishing SARS-CoV-2 persistence and reinfection, Novavax NVX-COV2373 triggers potent neutralization of Omicron sub-lineages, association between regular physical activity and the protective effect of vaccination against SARS-CoV-2 in a South African case, COVID-19 outcomes in solid organ transplant recipients who received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab treatment, Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralizing antibodies, and Tocilizumab versus Baricitinib in hospitalized patients with severe COVID-19.
TWiV 948: Breathless with David Quammen
By Vincent Racaniello | | This Week in Virology
David Quammen returns to TWiV to discuss how he wrote his new book 'Breathless', a story about the science and the scientists behind the race to understand the pandemic coronavirus SARS-CoV-2.
TWiV 947: Clinical update with Dr. Daniel Griffin
By Vincent Racaniello | | This Week in Virology
In his weekly clinical update Dr. Griffin discusses the prediction of upcoming global infection burden of influenza seasons after relaxation of public health and social measures during the COVID-19 pandemic, severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters, and how successful immunomodulators for treatment of COVID-19 have opened the pathway for comparative trials.
David Tuller
Trial By Error: NHS Lacks Policy on Severe ME, Per Testimony in Pre-Inquest Hearing on Death of Maeve Boothby O’Neill
By David Tuller, DrPH In January, I wrote a piece for Codastory.com about Maeve Boothby O’Neill, a young woman from Devon, England, who died from ME-related complications in October, 2021, at the age of 27. This week, at a pre-inquest hearing, it was revealed that the medical director of the hospital involved in Maeve’s care …
Trial By Error: Interview with Founders of The Sick Times, a New Online Publication
By David Tuller, DrPH Earlier this month, Betsy Ladyzhets and Miles Griffis, two smart, young American journalists, announced the launch The Sick Times, an online publication focused on long Covid and related post-acute infection syndromes, including ME/CFS. I have met both of them in the last couple of years and have been impressed with their …
Trial By Error: Interview with Founders of The Sick Times, a New Online Publication Read More »
Trial By Error: Column in Time Magazine Calls for Halt to Biomedical Long Covid Research
By David Tuller, DrPH *This is a crowdfunding month at UC Berkeley for my Trial by Error project. If you appreciate my work and would like to help support it, here’s the link for the November campaign. Time magazine recently published an opinion piece that calls for an end to biomedical research for long Covid—based, it seems, …
Trial By Error: Column in Time Magazine Calls for Halt to Biomedical Long Covid Research Read More »
Trial By Error: Cochrane Ends Silence on ME/CFS Exercise Review Developments
By David Tuller, DrPH *This is a crowdfunding month at UC Berkeley for my Trial by Error project. If you appreciate my work and would like to help support it, here’s the link for this November’s campaign. UPDATE: Cochrane has rejected Science For ME’s complaint, as discussed yesterday on a thread on the forum at around the …
Trial By Error: Cochrane Ends Silence on ME/CFS Exercise Review Developments Read More »
Trial By Error: Yet More Stupidity from the Dutch CBT Fan Club
By David Tuller, DrPH *This is a crowdfunding month at UC Berkeley for my Trial by Error project. If you appreciate my work and would like to help support it, here’s the link for this November’s campaign. As I pointed out last month when I reviewed a ridiculous study of “psychosomatic therapy” for “persistent somatic symptoms,” the …
Trial By Error: Yet More Stupidity from the Dutch CBT Fan Club Read More »
Trial By Error: A Conversation with Lisa McCorkell of the Patient-Led Research Collaborative
*This is a crowdfunding month at UC Berkeley for my Trial by Error project. If you appreciate my work and would like to help support it, here’s the link for this November’s campaign. By David Tuller, DrPH Lisa McCorkell is a co-founder of the Patient-Led Research Collaborative, a group of people with Long COVID and …